Stereotactic Body Radiotherapy Followed by Surgical Stabilization for Patients With Unstable Spinal Metastases: Cohort Study According to the IDEAL Recommendations
试验速览
- 阶段
- 不适用
- 状态
- 撤回
- 发起方
- UMC Utrecht
- 试验地点
- 1
- 主要终点
- Pain response
研究概览
简要总结
The aim of this study is to assess pain response after combining stereotactic body radiotherapy (SBRT) and pedicle screw fixation in a 48-hour window for the treatment of painful unstable metastases of the thoracic and/or lumbar spine.
详细描述
Rationale Sixty-five percent of cancer patients with terminal illness have bone metastases, with debilitating pain often as the severe consequence. The spine is the most common location for bone metastases. Standard treatment of unstable vertebral metastases consists of stabilizing surgery, followed by external beam radiotherapy after two weeks. Although this approach is effective in 60-70% of patients, it is has several downsides. Firstly, because of the two weeks interval between surgery and external beam radiotherapy, necessary for sufficient wound healing, it takes time before radiotherapy-induced pain relief is achieved. Moreover, the surgical implants used cause scatter artifacts on planning computed tomography images which prohibits high-resolution imaging and accurate targeting of the lesion. Multiple hospital visits (ranging from 1 to 10) are needed for administration of external beam irradiation, and in about 30-40% of patients no adequate pain response is achieved. An alternative treatment strategy, which would lead to faster pain relief in a higher proportion of patients with less hospital visits, would be highly desirable from the patient's perspective. Secondly, this strategy delays the start of systemic therapy.
Objective The main outcome of this study is pain response 4 weeks after start of the treatment.
Study design Prospective cohort study nested within the PRESENT cohort being a phase 2b study according to the IDEAL recommendations
Study population All patients, male and female, with impending spinal instability requiring surgical intervention and radiotherapy at the University Medical Center Utrecht
Intervention The combined treatment of stereotactic body radiotherapy and pedicle screw fixation in a 24 to 48-hour window for the treatment of painful unstable metastases of the cervical, thoracic and/or lumbar spine.
研究设计
- 研究类型
- Interventional
- 分配方式
- Na
- 干预模型
- Single Group
- 主要目的
- Treatment
- 盲法
- None
入排标准
- 年龄范围
- 18 Years 至 —(Adult, Older Adult)
- 性别
- All
- 接受健康志愿者
- 否
入选标准
- •Participation in PRESENT cohort
- •Painful radiosensitive metastases from solid tumors in the cervical, thoracic or lumbar spine needing surgical stabilization
- •Histologic proof of malignancy or radiographic/clinical characteristics indicating malignancy beyond reasonable doubt
- •Radiographic evidence of spinal metastases
- •Fit for (radio)surgery
- •Age > 18 years at the time of given informed consent in the PRESENT cohort.
- •Written informed consent
排除标准
- •SBRT cannot be delivered, e.g. in patients who cannot lie on the treatment table because of pain
- •Surgery cannot be performed, e.g. in patients with multiple spinal metastases that cannot be bridged
- •Previous surgery or radiotherapy to index lesion
- •Neurological deficits (ASIA C, B or A)
- •Partial neurological deficits (ASIA D) with rapid progression (hours to days)
- •Non-ambulatory patients
- •Patient in hospice or with < 3 months life expectancy
- •Medically inoperable or patient refused surgery
- •Radiosensitizing systemic treatment that cannot reasonably be stopped (for example immunotherapy and EGFR inhibitors)
结局指标
主要结局
Pain response
时间窗: 4 weeks
Pain response is defined as a decrease in initial worst pain score by at least 2 points on a Numeric Rating Scale (NRS) of 10 at the treated site, without increase in analgesic use, or an analgesic decrease of at least 25% without an increase in pain score
次要结局
- Neurological status(Through hospital stay, an average of 3 days)
- Duration of pain relief(Through hospital stay, an average of 3 days)
- Length of hospital stay(Through hospital stay, an average of 3 days)
- Adverse events(Through hospital stay, an average of 3 days)
- 30-day mortality(30 days)
- Neurological deterioration(Through hospital stay, an average of 3 days)
